Priveterra Acquisition Corp. (NASDAQ:PMGM) announced this afternoon that its special meeting, intended to approve its combination with AEON Biopharma, has been adjourned for the seventh consecutive time.
Given the SPAC’s completion deadline of August 11, it is unlikely that this will be the last adjournment we will see for this completion vote.
Initially scheduled for noon today, the meeting has now been pushed back until June 30 at 4:00 p.m. Priveterra continues to reiterate its commitment to utilizing the extended time during the postponement to further engage with its shareholders.
The deal with AEON Biopharma includes a $40 million minimum cash condition, half of which has already been secured through a $20 million commitment from existing AEON investors at $7 per share. But, Priveterra’s trust, originally totaling $276 million, has been reduced to about $20.3 million after seeing 92.7% of shares redeemed in earlier votes.
Priveterra inked its $201.8 million business combination with drug developer AEON on December 13. Irvine, California-based AEON is working on an injection-based migraine treatment to compete with Botox for chronic and frequent sufferers.
UY Scuti (NASDAQ:UYSCU) has filed for a $50 million SPAC to search for a middle market target using the team’s largely China-based network of contacts. This is so far the smallest offering ask of any SPAC filing this year and in fact no other team has sought to form a SPAC smaller than $55 million since...
Nabors Energy Transition Corp. II (NASDAQ:NETD) has signed a definitive agreement to combine with energy management firm e2Companies at an enterprise value of $770 million, or 26.8x its 2024 revenue. Bonita Springs, Florida-based e2 produces smart generators that electrify off-grid sites and provide power optimizing services to reduce energy costs at high-demand locations. The combined...
In this special follow-up edition of the SPACInsider Podcast, we check back in with Dimitre Genov, Ed Kovary, and Nick Skibo, who last joined us at the end of Q3 2024, to assess the state of the SPAC market in 2025 and the key dynamics shaping the landscape. Our panel brings together perspectives from across...
Texas Ventures Acquisition III Corp. (NASDAQ:TVACU) became the third SPAC to file for an IPO with Cohen & Company in a row Monday morning, but it has some distinct differences from its cousin SPACs on terms. While Cohen’s other recent pair Real Asset Acquisition Corp. (NASDAQ:RAAQU) and Digital Asset Acquisition Corp. (NASDAQ:DAAQU) have initially asked...
At the SPAC of Dawn Things are heating up with two more SPACs filing for IPOs, ballooning the past week’s total to six. These new filings include Cohen & Company’s fourth new S-1 filed as left lead underwriter in 2025 (five overall) and D Boral’s first of the year. These are paired in the news...